SCHEMBL1670342

SCHEMBL1670342

COc1ccc(Cn2c(-c3ccccc3)nc3c(/C=C/N(C)C)ccnc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 5/20 0.45
LMNA P02545 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
CNR2 P34972 1/20 0.45
TLR7 Q9NYK1 7/20 0.45
HPGD P15428 4/20 0.44
TP53 P04637 3/20 0.44
MAPT P10636 3/20 0.44
NPSR1 Q6W5P4 3/20 0.44
BLM P54132 1/20 0.42
GAA P10253 3/20 0.42
PDE4B Q07343 1/20 0.42
NPC1 O15118 1/20 0.39
GLA P06280 1/20 0.39
NFKB1 P19838 1/20 0.39
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1670343 1.00 HTT (0.45) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL6950561 0.86 ALDH1A1 (0.48) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL6949121 0.82 HTT (0.53) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL7498958 0.69 ALDH1A1 (0.68) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5062834 0.69 TLR7 (0.41) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL22438726 0.68 DCTPP1 (0.54) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL6949006 0.68 SMN1; SMN2 (0.40) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL10443668 0.65 ALDH1A1 (0.92) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL26102320 0.65 ALDH1A1 (0.45) HTTSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL16380992 0.65 SMN1; SMN2 (0.47) HTTSMN1; SMN2ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308870-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed